Product Code: ETC4759217 | Publication Date: Nov 2023 | Updated Date: Apr 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Vaccines Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 New Zealand Vaccines Market - Industry Life Cycle |
3.4 New Zealand Vaccines Market - Porter's Five Forces |
3.5 New Zealand Vaccines Market Revenues & Volume Share, By Technology, 2020 & 2030F |
3.6 New Zealand Vaccines Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.7 New Zealand Vaccines Market Revenues & Volume Share, By Disease Indication, 2020 & 2030F |
3.8 New Zealand Vaccines Market Revenues & Volume Share, By Route of Administration, 2020 & 2030F |
3.9 New Zealand Vaccines Market Revenues & Volume Share, By Patient Type, 2020 & 2030F |
4 New Zealand Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 New Zealand Vaccines Market Trends |
6 New Zealand Vaccines Market Segmentations |
6.1 New Zealand Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Vaccines Market Revenues & Volume, By Conjugate vaccines, 2020-2030F |
6.1.3 New Zealand Vaccines Market Revenues & Volume, By Inactivated and subunit vaccines, 2020-2030F |
6.1.4 New Zealand Vaccines Market Revenues & Volume, By Live attenuated vaccines, 2020-2030F |
6.1.5 New Zealand Vaccines Market Revenues & Volume, By Recombinant vaccines, 2020-2030F |
6.1.6 New Zealand Vaccines Market Revenues & Volume, By Toxoid vaccines, 2020-2030F |
6.2 New Zealand Vaccines Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Vaccines Market Revenues & Volume, By Monovalent vaccines, 2020-2030F |
6.2.3 New Zealand Vaccines Market Revenues & Volume, By Multivalent vaccines, 2020-2030F |
6.3 New Zealand Vaccines Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Vaccines Market Revenues & Volume, By Pneumococcal disease, 2020-2030F |
6.3.3 New Zealand Vaccines Market Revenues & Volume, By DTP, 2020-2030F |
6.3.4 New Zealand Vaccines Market Revenues & Volume, By Influenza, 2020-2030F |
6.3.5 New Zealand Vaccines Market Revenues & Volume, By HPV, 2020-2030F |
6.3.6 New Zealand Vaccines Market Revenues & Volume, By Meningococcal disease, 2020-2030F |
6.3.7 New Zealand Vaccines Market Revenues & Volume, By Polio, 2020-2030F |
6.3.8 New Zealand Vaccines Market Revenues & Volume, By Other disease indications, 2020-2030F |
6.3.9 New Zealand Vaccines Market Revenues & Volume, By Other disease indications, 2020-2030F |
6.4 New Zealand Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Vaccines Market Revenues & Volume, By Intramuscular and subcutaneous administration, 2020-2030F |
6.4.3 New Zealand Vaccines Market Revenues & Volume, By Oral administration, 2020-2030F |
6.4.4 New Zealand Vaccines Market Revenues & Volume, By Other routes of administration, 2020-2030F |
6.5 New Zealand Vaccines Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Vaccines Market Revenues & Volume, By Pediatric patients, 2020-2030F |
6.5.3 New Zealand Vaccines Market Revenues & Volume, By Adult patients, 2020-2030F |
7 New Zealand Vaccines Market Import-Export Trade Statistics |
7.1 New Zealand Vaccines Market Export to Major Countries |
7.2 New Zealand Vaccines Market Imports from Major Countries |
8 New Zealand Vaccines Market Key Performance Indicators |
9 New Zealand Vaccines Market - Opportunity Assessment |
9.1 New Zealand Vaccines Market Opportunity Assessment, By Technology, 2020 & 2030F |
9.2 New Zealand Vaccines Market Opportunity Assessment, By Type, 2020 & 2030F |
9.3 New Zealand Vaccines Market Opportunity Assessment, By Disease Indication, 2020 & 2030F |
9.4 New Zealand Vaccines Market Opportunity Assessment, By Route of Administration, 2020 & 2030F |
9.5 New Zealand Vaccines Market Opportunity Assessment, By Patient Type, 2020 & 2030F |
10 New Zealand Vaccines Market - Competitive Landscape |
10.1 New Zealand Vaccines Market Revenue Share, By Companies, 2023 |
10.2 New Zealand Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |